T. Waldman
Molecular Biology · 2004–2009
A researcher in the Science corpus: 2 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 24 citations into it
- Oncology — 10 citations into it
Whom T. Waldman trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Lewis C. Cantley (in Molecular Biology)
- Alan Ashworth (in Molecular Biology)
- W. Kaelin (in Molecular Biology)
- S. West (in Molecular Biology)
Papers from T. Waldman's perspective
Ordered by how strongly the researchers T. Waldman trusts endorse each paper. Same corpus, a different order for every researcher.
- High Frequency of Mutations of the PIK3CA Gene in Human Cancers (Science)
- The PIK3CA gene is mutated with high frequency in human breast cancers (Cancer Biology & Therapy)
- The phosphoinositide 3-kinase pathway. (Science)
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancer (Nature Reviews. Cancer)
- Mutation of the PIK3CA Gene in Ovarian and Breast Cancer (Cancer Research)
- Cellular function of phosphoinositide 3-kinases: Implications for development, immunity, homeostasis, and cancer
- PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. (Cancer Research)
- Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis (Nature)
- Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. (Proceedings of the National Academy of Sciences of the United States of America)
- Tenets of PTEN tumor suppression. (Cell)
Their papers
- Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors (2009) — 674 citations
- Oncogenic mutations of PIK3CA in human cancers. (2004) — 661 citations